Clin2
NCT04319627Possibly a fitRecruiting

Statins to prevent new blood clots after leg clot or lung clot

Venous ThromboembolismBlood ClotPost Thrombotic Syndrome

Part of Heart & circulation clinical trials.

This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,700 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a recent, confirmed blood clot: DVT in the upper part of the leg vein and/or a lung clot diagnosed within the last 30 days
  • You can provide written informed consent (or your legal representative can, if applicable)
  • You’re 18 or older
  • You are not already taking a statin
  • You can safely take rosuvastatin (not allergic to statins, no serious muscle or liver/kidney problems, and not on certain drug combinations)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07303816Recruiting· Phase 4
Can statins prevent blood clots in cancer patients?

This trial tests whether a daily statin (rosuvastatin) can help prevent dangerous blood clots in people with advanced cancer who are starting new cancer therapy. It is for those at medium or high risk for clots, based on a simple risk score.

Boston, Massachusetts
NCT04257487Recruiting· Phase 3
Sulodexide to prevent blood clots from coming back

This study tests sulodexide (a blood-vessel protective medicine) to help stop deep leg blood clots or lung clots from returning after you’ve already been treated. It may help people with higher bleeding risk who are taking or recently finished standard anticoagulant medicines.

Rozzano
NCT06440694Recruiting· Phase 3
Colchicine to reduce inflammation after a first blood clot in the leg

This trial tests if colchicine, a medicine used for gout, can reduce inflammation after a first deep vein thrombosis (blood clot in a large leg vein). It might help prevent long-term leg problems from the clot.

Ottawa, Ontario
NCT05735639Recruiting· Phase 4
Prevention of blood clots during varicose vein treatment

This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.

London
NCT07344610Recruiting
Short-term high-dose statin therapy after stroke

This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.

Shenyang, Liaoning
NCT07401017Not yet recruiting
Rosuvastatin and running: a heart health study

This trial tests if the cholesterol-lowering drug rosuvastatin affects how your body adapts to running training. You may join if you are a long-distance runner who needs statin therapy and are willing to track your workouts with a sports watch.

Taipei

Hear when a new Venous Thromboembolism trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.